HeartBeam, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

STOCKHOLDERS??? EQUITY - Common Stock (Details)

STOCKHOLDERS’ EQUITY - Common Stock (Details)							12 Months Ended
STOCKHOLDERS’ EQUITY - Common Stock (Details)	Feb. 28, 2022 $ / shares shares	Feb. 18, 2022 USD ($) $ / shares shares	Jan. 14, 2022 $ / shares shares	Nov. 15, 2021 $ / shares	Nov. 10, 2021 USD ($) $ / shares shares	Sep. 27, 2021	Dec. 31, 2022 USD ($) $ / shares shares	Dec. 31, 2021 USD ($) $ / shares shares	Nov. 14, 2022 $ / shares	Dec. 31, 2020 $ / shares
Subsidiary, Sale of Stock [Line Items]
Exercise price of warrants (in dollars per share)				$ 7.50			$ 5.42	$ 5.42		$ 0.11
Period which warrants are exercisable				5 years
Conversion of debt to equity \| $							$ 0	$ 6,288,000
Common stock issuance upon vesting and exercise of stock options (in shares) \| shares							38,806	34,846
Reverse stock split ratio, common stock						0.3636
Common stock, par value (in dollars per share)		$ 0.0001					$ 0.0001	$ 0.0001	$ 0.0001
Number of share based payment awards, exercised in period (in shares) \| shares							63,806	34,846
2015 Notes \| Convertible debt
Subsidiary, Sale of Stock [Line Items]
Shares issued in IPO, price per share (in dollars per share)							$ 4.20
Conversion of debt to equity \| $					$ 5,084,000
Conversion of debt to equity, accrued interest \| $					$ 1,204,404
Number of units issued in debt conversion (in shares) \| shares					1,497,216
Conversion price (in dollars per share)					$ 4.20
Common Stock
Subsidiary, Sale of Stock [Line Items]
Common stock issuance upon vesting and exercise of stock options (in shares) \| shares							38,806	34,846
Warrants
Subsidiary, Sale of Stock [Line Items]
Exercise price of warrants (in dollars per share)	$ 6.00
Stock issued for service (in shares) \| shares	58,000
IPO
Subsidiary, Sale of Stock [Line Items]
Shares issued in IPO (in shares) \| shares					2,750,000
Exercise price of warrants (in dollars per share)					$ 6.00
Period which warrants are exercisable					5 years
Proceeds from initial public offering \| $					$ 14,713,000
Underwriting discount and commissions and other expenses \| $					$ 1,800,000
IPO \| Common Stock
Subsidiary, Sale of Stock [Line Items]
Shares issued per each unit (in shares) \| shares					1
Shares issued in IPO, price per share (in dollars per share)					$ 0.0001
IPO \| Common Stock \| Consultants
Subsidiary, Sale of Stock [Line Items]
Exercise price of warrants (in dollars per share)			$ 5.50		$ 5.50
Stock issued for service (in shares) \| shares					78,025
Stock issued for service \| $					$ 365,000
Warrant expiration period			5 years		5 years
Warrant fair value (in dollars per share)					$ 1.25
Fair value assumptions, fair value per share (in dollars per share)					$ 2.28
Expected volatility rate					90.81%
Expected dividend rate					0.00%
Risk-free rate					0.87%
Expected term (in years)					5 years
Fair value of warrants issued for service \| $					$ 91,000
IPO \| Warrants
Subsidiary, Sale of Stock [Line Items]
Shares issued per each unit (in shares) \| shares					1
Shares issued in IPO, price per share (in dollars per share)					$ 6.00
Exercise price of warrants (in dollars per share)					$ 6.00
Period which warrants are exercisable					5 years
IPO \| Warrants \| Consultants
Subsidiary, Sale of Stock [Line Items]
Stock issued for service (in shares) \| shares			72,727		72,727
Private Placement \| OpenSky Opportunities Fund Ltd.
Subsidiary, Sale of Stock [Line Items]
Shares issued in IPO (in shares) \| shares		58,000
Shares issued in IPO, price per share (in dollars per share)		$ 6.00
Proceeds from issuance of private placement \| $		$ 348,000
Private Placement \| Common Stock \| OpenSky Opportunities Fund Ltd.
Subsidiary, Sale of Stock [Line Items]
Shares issued per each unit (in shares) \| shares		1
Period which warrants are exercisable		5 years